Previous close | 175.82 |
Open | 177.03 |
Bid | 175.54 x 1200 |
Ask | 175.57 x 800 |
Day's range | 173.72 - 178.41 |
52-week range | 169.13 - 279.02 |
Volume | |
Avg. volume | 2,166,103 |
Market cap | 51.908B |
Beta (5Y monthly) | 1.61 |
PE ratio (TTM) | 8.30 |
EPS (TTM) | 21.16 |
Earnings date | 18 July 2022 - 22 July 2022 |
Forward dividend & yield | 2.24 (1.25%) |
Ex-dividend date | 15 June 2022 |
1y target est | 253.73 |
HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.
HCA Healthcare (HCA) closed at $179.82 in the latest trading session, marking a -1.38% move from the prior day.
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.